Siri Sæterstad Selected Research

O- (5- O- (4- coumaroyl)- alpha- arabinofuranosyl)- (1- 3)- O- beta- xylopyranosyl- (1- 4)- xylopyranose

1/2019	Synthetic lethality between DNA repair factors Xlf and Paxx is rescued by inactivation of Trp53.
1/2018	Normal development of mice lacking PAXX, the paralogue of XRCC4 and XLF.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siri Sæterstad Research Topics

Disease

2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Ulcerative Colitis 01/2022 - 12/2020
2	Crohn Disease (Crohn's Disease) 01/2022 - 12/2020
1	Colitis 12/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2020
1	Ileitis 12/2020
1	Genomic Instability 01/2019
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2020
2	O- (5- O- (4- coumaroyl)- alpha- arabinofuranosyl)- (1- 3)- O- beta- xylopyranosyl- (1- 4)- xylopyranoseIBA 01/2019 - 01/2018
2	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Messenger RNA (mRNA)IBA 12/2020
1	Serotonin (5 Hydroxytryptamine)IBA 12/2020

Therapy/Procedure

2	Lasers (Laser) 01/2022 - 12/2020